This Article Abstract Full Text Full Text (PDF) View CVN Genuine Article View Related Story on Cardiosmart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Gazzaruso, C. Articles by Garzaniti, A. Search for Related Content PubMed PubMed Citation Articles by Gazzaruso, C. Articles by Garzaniti, A. Related Collections Related Articles

Erectile Dysfunction as a Predictor of Cardiovascular Events and Death in Diabetic Patients With Angiographically Proven Asymptomatic Coronary Artery Disease

A Potential Protective Role for Statins and 5-Phosphodiesterase Inhibitors

Carmine Gazzaruso, MD, PhD^_*,_*, Sebastiano B. Solerte, MD, Arturo Pujia, MD, Adriana Coppola, RN, MS^_*, Monia Vezzoli, MD^_*, Fabrizio Salvucci, MD^_*, Cinzia Valenti, MD^_*, Andrea Giustina, MD^|| and Adriana Garzaniti, MD

^_* Cardio-Metabolic Unit and the Centre for Applied Clinical Research (Ce.R.C.A.) Clinical Institute "Beato Matteo," Hospital Group San Donato, Vigevano, Italy
Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy
Diabetes Centre, A.O. Province of Pavia, Pavia, Italy
Department of Experimental and Clinical Medicine, University of Catanzaro, Catanzaro, Italy
^|| Endocrinology Unit, University of Brescia, Brescia, Italy.

View larger version (13K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Kaplan-Meier Analysis in Diabetic Patients With Silent Coronary Artery Disease Event-free survival estimate according to presence/absence of erectile dysfunction (ED).

View larger version (14K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Kaplan-Meier Analysis in Diabetic Patients With Silent CAD and ED Event-free survival estimate according to the use of 5-phosphodiesterase (5-PDE) inhibitors. CAD = coronary artery disease; ED = erectile dysfunction.